Zinc deficiency depresses p21 gene expression: Inhibition of cell cycle progression is independent of the decrease in p21 protein level in HepG2 cells

American Journal of Physiology - Cell Physiology

Volumn 292, Issue 6, 2007, Pages

  Wong, Stephen H K ^a   Zhao, Yangqing ^a   Schoene, Norberta W ^b   Han, Chung Ting ^a   Shih, Rita S M ^a   Lei, Kai Y ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Human hepatoblastoma cells; p21 mRNA; p21 promoter accessibility; Zinc status

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; PROTEIN P21; ZINC;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL CYCLE PROGRESSION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DOWN REGULATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HEPATOBLASTOMA; HUMAN; HUMAN CELL; INHIBITION KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; SUPPLEMENTATION; ZINC BLOOD LEVEL; ZINC DEFICIENCY;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HEPATOBLASTOMA; HUMANS; ZINC;

CYTOMEGALOVIRUS;

EID: 34447540372     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00256.2006     Document Type: Article

References (38)

1. Alshatwi AA, Han CT, Schoene NW, Lei KY. Nuclear accumulations of p53 and Mdm2 are accompanied by reductions in c-Abl and p300 in zinc depleted human hepatoblastoma cells. Exp Biol Med (Maywood) 231: 611-618, 2006.
2. Arango D, Mariadason JM, Wilson AJ, Yang W, Corner GA, Nicholas C, Aranes MJ, Augenlicht LH. c-Myc overexpression sensitizes colon cancer cells to camptothecin-induced apoptosis. Br J Cancer 89: 1757-1756, 2003.
3. Bendjennat M, Boulaire J, Jascur T, Brickner H, Barbier V, Sarasin A, Fotedar A, Fotedar R. UV irradiation triggers ubiquitin-dependent degradation of p21/WAF1 to promote DNA repair. Cell 114: 599-610, 2003.
4. Benzeno S, Narla G, Allina J, Cheng GZ, Reeves HL, Banck MS, Odin JA, Diehl JA, Germain D, Friedman SL. Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1. Cancer Res 64: 3885-3891, 2004.
5. Bloom J, Amador V, Bartolini F, DeMartino G, Pagano M. Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation. Cell 115: 71-82, 2003.
6. 2+ requirement for DNA synthesis by 3T3 cells. Exp Cell Res 192: 631-634, 1991.
7. Cui L, Schoene NW, Zhu L, Fanzo JC, Alshatwi A, Lei KY. Zinc depletion reduced Egr-1 and HNF-3β expression and apolipoprotein A-I promoter activity in Hep G2 cells. Am J Physiol Cell Physiol 283: C623-C630, 2002.
8. Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and vivo in the scid mouse brain. J Biol Chem 280: 6802-6815, 2005.
9. El-Deiry W, Tokino T, Velculescu V, Levy D, Parsons R, Trent J, Lin D, Mercer WE, Kinzler K, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993.
10. El-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculscu VE, Burrel M, Hill DE, Healy E, Rees JL, Hamilton SR, Kinzler KW, Vogelstein B. Topological control of p21 (WAF1/CIP1) expression in normal and neoplastic tissues. Cancer Res 55: 2910-2919, 1995.
11. Fanzo JC, Reaves SK, Cui L, Zhu L, Lei KY. p53 protein and p21 mRNA levels and caspase-3 activity are altered by zinc status in aortic endothelial cells. Am J Physiol Cell Physiol 283: C631-C638, 2002.
12. Fanzo JC, Reaves SK, Cui L, Zhu L, Wu JY, Wang YR, Lei KY. Zinc status affects p53, gadd45, and c-fos expression and caspase-3 activity in human bronchial epithelial cells. Am J Physiol Cell Physiol 281: C751-C757, 2001.
13. Fraker PJ, Telford WG. A reappraisal of the role of zinc in life and death decisions of cells. Proc Soc Exp Biol Med 215: 229-236, 1997.
14. Gartel AL, Tyner AL. Transcriptional regulation of the p21 (WAF1/CIP1) gene. Exp Cell Res 246: 280-289, 1999.
15. Haiunaut P, Milner J. A structural role for metal ions in the "wild-type" conformation of the tumor suppressor gene p53. Cancer Res 53: 1739-1742, 1993.
16. Huang L, Sowa Y, Sakai T, Pardee AB. Activation of the p21 WAF1/CIP1 promoter independent of p53 by the histone deactylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites. Oncogene 19: 5712-5719, 2000.
17. Kadam S, Emerson BM. Mechanisms of chromatin assembly and transcription. Curr Opin Cell Biol 14: 262-268, 2002.
18. Kalkhoven E. CBP and p300: HAT for different occasions. Biochem Pharmacol 68: 1145-1155, 2004.
19. Kavurma MM, Khachigian LM. Sp1 inhibits proliferation and induces apoptosis in vascular smooth muscle cells by repressing p21WAF1/Cip1 transcription and cyclin D1-Cdk4-p21WAF1/Cip1 complex formation. J Biol Chem 278: 32537-32543, 2003.
20. Kavurma MM, Khachigian LM. Vascular smooth muscle cell-specific regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1) transcription by Sp1 is mediated via distinct cis-acting positive and negative regulatory elements in the proximal p21(WAF1/Cip1) promoter. J Cell Biochem 93: 904-916, 2004.
21. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E. New functional activities for the p21 family of CDK inhibitors. Genes Dev 11: 847-862, 1997.
22. Lagger G, Doetzlhofer A, Schuettengruber B, Haidweger E, Simboeck E, Tischler J, Chiocca S, Suske G, Rotheneder H, Wintersberger E, Seiser C. The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene. Mol Cell Biol 23: 2669-2679, 2003.
23. Li Y, Dowbenko D, Lasky LA. AKT/PKB phosphorylation of p21Cip1/WAF1 enhances protein stability of p21Cip1/WAF1 and promotes cell survival. J Biol Chem 277: 11352-11361, 2002.
24. Liu G, Xia T, Chen X. The activation domains, the proline-rich domain, and the C-terminal basic domain in p53 are necessary for acetylation of histones on the proximal p21 promoter and interaction with p300/CREB-binding protein. J Biol Chem 278: 17557-17565, 2003.
25. MacDonald RS. The role of zinc in growth and cell proliferation. J Nutr 130: 1500S-1508S, 2000.
26. Maki CG, Howley PM. Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol Cell Biol 17: 355-363, 1997.
27. Niculescu AR, Chen X, Smeets M, Hengst L, Prives C, Reed SI. Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol 18: 629-643, 1998.
28. Noseda M, Chang L, McLean G, Grim JE, Clurman BE, Smith LL, Karsan A. Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: role of p21Cip1 repression. Mol Cell Biol 24: 8813-8822, 2004.
29. Ogryzko VV, Wong P, Howard BH. WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases. Mol Cell Biol 17: 4877-4882, 1997.
30. Ono T, Kitaura H, Ugai H, Murata T, Yokoyama KK, Ariga SMI, Ariga H. TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase. J Biol Chem 40: 31145-31154, 2000.
31. Pietenpol JA, Stewart ZA. Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology 181-182: 475-481, 2002.
32. Reaves SK, Fanzo JC, Arima K, Wu JY, Wang YR, Lei KY. Expression of the p53 tumor suppressor gene is up-regulated by depletion of intracellular zinc in HepG2 cells. J Nutr 130: 1688-1694, 2000.
33. Sheaff RJ, Singer JD, Swanger J, Smitherman M, Roberts JM, Clurman BE. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol Cell Biol 5: 403-410, 2000.
34. Smirnova IV. Zinc and cadmium can promote rapid nuclear translocation of metal responsive element-binding transcription factor-1. J Biol Chem 275: 9377-9384, 2000.
35. Swanton C. Cell-cycle targeted therapies. Lancet Oncol 5: 27-36, 2004.
36. Wu FY, Wu CW. Zinc in DNA replication and transcription. Annu Rev Nutr 7: 251-272, 1987.
37. Xiong Y, Hannon G, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704, 1993.
38. Yin Y, Zhu A, Jin Y, Liu Y, Zhang X, Hopkins KM, Lieberman HB. Human RAD9 checkpoint control/proapoptotic protein can activate transcription of p21. Proc Natl Acad Sci USA 101: 8864-8869, 2004.